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ABSTRACT 
The objectives of the study were to investigate the effects of age, calendar period, and 
birth cohort on the development of cognitive impairment among the elderly, and to 
identify factors possibly moderating these effects. Harmonized data were drawn from 
two community-based cohort studies. A total of 3,021 participants, born after 1895, age 
65 years or older with normal cognitive capacities were recruited during 1987-2008 and 
followed for more than 10 years. Cognitive capability was evaluated periodically using 
the Clinical Dementia Rating (CDR) scale. Incident mild cognitive impairment (MCI) was 
defined as the CDR value reaching 0.5. Age-period-cohort (APC) modelling approach 
was used to evaluate three time-varying effects on the development of MCI. 
Confounding and moderating effects of gender, education, and ApoE4 allele were also 
examined. Our analysis results showed that age was the most significant time-
dependent factor affecting the MCI incident rates. Within the same calendar period and 
birth cohort, the MCI rate in the older elderly was significantly higher compared with the 
younger elderly population. A significant period effect was observed in which the MCI 
incidence rates were decreasing from the period of 1990-1994 through 2015 after 
controlling for age and birth cohort. No significant cohort effect was found. Gender 
showed no significant confounding or moderating effects. The age effects on MCI 
Chung-Chou H. Chang, PhD 
AGE-PERIOD-COHORT EFFECTS ON THE DEVELOPMENT OF COGNITIVE 
IMPAIRMENT AMONG THE ELDERLY 
Xinmei Zhu, MS 
University of Pittsburgh, 2017
 
 v 
incidence rate was not moderated or confounded by education, while the period effects 
were significantly confounded by education. The cohort effect was significantly 
moderated by education. The cohort effects on MCI incidence rates for individuals who 
received HS education or higher education were different depending on the levels of 
education. ApoE4 allele did not show a significant moderating effect. 
Public Health Significance 
The APC model shows advantages over the traditional modelling approaches as it 
dissects the independent effects of age, period, and cohort. For public health, chronic 
disease prevalence often reflects a combination of processes that vary by these three 
factors. Better understanding the impacts of these time-dependent factors on disease 
rates help to guide hypotheses about etiologic mechanisms, and more importantly, 
guides researchers in conducting and presenting surveillance with the best practices.  
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1.0  INTRODUCTION 
Dementia or cognitive impairment is an age-related disorder associated with the senior 
population. The prevalence of dementia increases exponentially with age and it has 
been a leading cause of disability and dependence among the elderly [1]. It had been 
predicted that a worldwide figure of 81.1 million people will be affected by dementia by 
2040, if there is no curative treatment developed by then [2]. Alzheimer's disease (AD) 
is the most common form of dementia. Studies showed that mild cognitive impairment 
(MCI) without dementia is even more prevalent in the United States than dementia [3]. It 
was observed that people with MCI are likely to progress to dementia at a rate of 
approximately 12% per year, compared with 1 to 2% for cognitively normal people at the 
same age [4-6]. Considering declined quality of life and economic burdens among 
patients and their families, cognitive impairment and AD are becoming a major public 
health problem [7]. 
It has been well known that cognitive decline could be a normal process of aging, 
and the age effects on the development of cognitive impairment (CI) are well 
documented in the scientific literatures. Many published studies employed a cross-
sectional design to compare subjects from different age groups [8]. These studies were 
subject to confounding due to cohort differences, as people born in different cohorts 
may have a very different life experience in terms of culture, lifestyle, education, and 
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social-economic environment [8]. As a result, subjects from one age cohort could 
perform poorly on the cognitive test as compared to subjects from a different age cohort 
[9]. Then it is not surprising that effects of aging in cross-sectional studies could be 
confounded by cohort differences and potentially could be overestimated [10, 11]. 
Similarly, at certain periods, people may experience some widespread environmental 
changes and population-wide exposures that were associated with cognitive decline, 
then the effects of calendar period, could be another confounding factor of aging effects 
within the existing studies. Given such a situation, we believe all those time related 
factors, age, calendar period, and birth cohort, could affect the development of 
incidence rates of CI in different ways. Our study aimed to identify the critical temporal 
factors that may influence the development of MCI. For this purpose, two promising 
prospective community-based cohort studies, Monongahela Valley Independent Elders 
Survey (MoVIES) and Mon-Yough Health Aging Team (MYHAT) were designed and 
performed. There were 1,608 individuals aged 65 years or older between 1987 and 
1989 recruited for MoVIES project to investigate the incidence, risk factors, and 
outcome in late-life dementia. MYHAT is an on-going project seeking to describe the 
distribution of cognitive Impairment and its associated features, its outcomes over time, 
and the predictors of these outcomes. Approximately 1,413 were recruited and 
assessed periodically to determine their cognitive capability status. Clinical dementia 
rating (CDR) is a 5-point scale used to characterize the participants’ cognitive 
performances applicable to Alzheimer disease and the related cognitive impairment. In 
here we harmonized data from MoVIES and MYHAT studies according to their CDR 
scores. Incident MCI was defined as the CDR value reaching 0.5.  
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To characterize the temporal effects of age, calendar period, and birth cohort on 
the development of CI, we used an age-period-cohort (APC) model to dissect the roles 
of these three time-related factors in the development of MCI. Each component of the 
APC model provided different insights into the trends of the disease over time. The APC 
analysis gave us an overview of the magnitude of rates and the variation of rates by 
these three time-varying components [12].  
Cognitive impairment is a complicated age-related disorder resulting from 
interaction of multiple risk factors including genetic, vascular, and other unknown risk 
factors. Apolipoprotein E (ApoE) ε4 allele is a known genetic risk factor for AD [13, 14]. 
Moreover, it was reported that progress of MCI to AD is accelerated by ApoE4 [15, 16]. 
Within this study, we also investigated whether ApoE4 allele expression would 
moderate the temporal effects on the MCI incidence rates. Other potential confounders 
and possible moderators such as gender and education were also examined.  
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2.0  MATERIALS AND METHODS 
2.1 STUDY POPULATION 
Data were drawn from MoVIES and MYHAT which were two independent prospective 
cohort studies designed to identify factors that are associated with cognitive impairment 
among the community-dwelling older adults (age 65 years or older). There were 1,608 
participants recruited between 1987 and 1989 for MoVIES and followed over 15 years, 
while 1,413 participants were recruited between 2006 and 2008 for MYHAT and 
followed for about 10 years (which was summarized in Figure 1 and supplementary 
Table 1). The outcome variable of interest was the incidence rates of MCI where MCI 
was defined by reaching 0.5 or greater on the CDR scale. The main exposure variables 
of interest included age, calendar year, and birth year at the time of study entry. Gender 
and education information, which are potential confounders and may possibly moderate 
the effects of temporal factors on the development of MCI were collected. Known 
genetic risk factor for dementia, ApoE4 allele genotyping of participants was tested 
during the study period. Periodical follow-up assessments were performed to track 
change in cognitive capabilities. For the MoVIES project, the home interviews were 
repeated approximately every two years for a total of 15 years, while for the MYHAT 
5 
project an annual follow-up assessment was made (which was summarized in 
Supplementary Table 2). 
As shown in Figure 1, a total of 3,021 participants (1,608 from MoVIES and 
1,413 from MYHAT) with normal cognitive capacities (CDR = 0) were included for this 
study. After excluding subjects whose first interview date was the same as the last 
follow-up date, our final analytic data set includes 2,772 subjects.  
 
 
Figure 1. Consort diagram for data collection information 
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2.2 STATISTICAL ANALYSIS 
2.2.1 APC model 
We examined the temporal effects of age, calendar period, and birth cohort on the risk 
of incident MCI using the APC model approach [17-19]. APC model is a popular tool for 
dissecting the independent effects of all three time-dependent variables (age, period, 
and cohort) and has received considerable attention in statistical field [20-22]. The 
model is based on a Poisson log-linear model for the expected rates with additive 
effects of age, period, and cohorts. The model has the form 
 Ln(Mij ) =Ln(θij /Nij)= µ + αi + βj + γk,     (1) 
where Mij is the MCI incidence rate for individuals in age group i at calendar time j; θij is 
the number of incident cases among individuals in age group i at calendar time j; Nij is 
the number of follow-up person-years for individuals in age group i at calendar time j; µ 
is the overall expected mean log incidence rate; αi, βj, and γk are the differential rates 
from the overall mean log incidence rate for individuals in age group i, calendar time j, 
and birth cohort k, respectively.  
When we apply an APC model, it is important to recognize the non-identifiability 
issue resulted from collinearity among these three variables (Cohort = Period − Age), 
which makes simultaneous mathematical modeling of the linear functions of three 
effects impossible without additional restrictions [11]. To resolve this identifiability issue, 
existing literatures have reported a variety of methodological approaches [11, 23-25]. 
One method suggested is to use a reduced set of covariates (reduced APC model) in 
the model by including age and period without including birth cohort. In this two-factor 
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model, cohort effects can be considered as a special form of interaction effects between 
age and period [26]. Another popular approach to resolve the identification problem was 
the constraint-based regression analysis. In this strategy, at least one category of age, 
period, and cohort is constrained in some manner by assuming that some categories of 
age groups, cohorts, or time periods have identical effects on the dependent variable 
[22], thus it became possible to estimate independent effect of age period and cohort 
[19]. It is worth noting that the results from the constraint-based on full APC model might 
be sensitive to the constraints that investigators chosen and sometimes the validity of 
the chosen constraints cannot be confirmed [27-29]. To select the appropriate and 
reasonable constraints, investigators often use graphical data that describes the 
disease trends by period, age, and cohort to establish the choice of constraints for this 
model [30].  
2.2.2 Data analysis  
We analyzed the data in the following steps. First, we classified age into 7 five-year 
groups (65-69, 70-74, 75-79, 80-84, 85-89, 90-94, and 95-99 years old), calendar time 
into 7 five-year periods (1985-1989, 1990-1994, 1995-1999, 2000-2004, 2005-2009, 
2010-2014, and 2015 after), and birth year into 10 five-year birth cohorts (1895-
1899,1900-1904, 1905-1909, 1910-1914, 1915-1919, 1920-1924, 1925-1929, 1930-
1934, 1935-1939, and 1940 or after). Second, age-specific MCI incidence rates per 
1,000 person-years were calculated for each of the 7 five-year age groups, each of the 
7 five-year calendar periods, and each of the 10 five-year birth cohorts. We employed 
the lexis diagram to depict the MCI incidence rates among different birth cohorts. The 
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diagram is a two-dimensional figure where horizontal-axis and the vertical axis 
represent the calendar time and age, respectively. The straight line in the diagram is 
called an individual’s life line, which begins at the time/age of study entry and continues 
diagonally upwards and ends at the time/age of the individual’s last follow-up (either 
events occurred or last time/age followed). Third, we fit the data into a reduced APC 
model (one or two temporal factors instead of all 3 factors together) which provided us 
with unique (but not independent) information of the temporal effects on MCI incidence 
rates [26]. And in here we would expect to see a possible trend that certain groups 
would not show significant effects on the MCI incidence rates. We further examine if 
there are two period groups (or birth cohort) having similar effects, which can be chosen 
as the constraints in the full APC Model. We then fit the data into the full APC model 
with constraints to simultaneously estimate the independent effects of all 3 temporal 
factors. We confirmed the validity of our constraint choice by selecting different birth 
cohorts and period groups as constraints and regenerated the analysis results. We 
finally used the Akaike information criterion (AIC) to choose the best APC model among 
restricted one-factor, restricted two-factor, and full model with different constrains.  
2.2.3 Statistical software 
All analyses were performed using R version 3.3.3. We included the R codes of our 
data analyses to the Appendix. 
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2.3  ETHICAL CONSIDERATION 
The community-wide recruitment, and assessment procedures were approved by the 
Institutional Review Board at University of Pittsburgh. 
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3.0  RESULTS 
3.1 DESCRIPTIVE ANALYSIS RESULTS 
1. Descriptive Analysis Results 
The harmonized MoVIES and MYHAT data contain 3,021 subjects and 13 variables, as 
shown in Figure 1 and Supplementary Table 1. Among these 3,021 observations, 
1,608 records were from MoVIES and the remaining 1,413 records were from MYHAT. 
We excluded 94 records from MoVIES and 155 records from MYHAT for the final 
analysis, because the first interview date and the last follow-up date were the same for 
each of the excluded subjects. Therefore, the final analytic sample contains 2,772 
subjects. The lexis diagram in Figure 2 depicts the ages and the calendar dates of entry 
and exit for all 2,772 subjects. Each line on the diagram represents the follow-up time 
span. If the end of the line has a solid red dot, the corresponding participant 
experienced MCI incidence at that time point. The lexis diagram shows that there was a 
gap between the two studies (Year 2002 through 2006) where there was no participant 
involved in the studies.  
There were 655 MCI cases (total incidence rate 35.7 per 1,000 person-years) for 
the harmonized data, 305 MCI cases from the MoVIES project (incidence rate 24.9 per 
1,000 person-years), and 350 MCI cases from the MYHAT project (incidence rate 57.4 
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per 1,000 person-years), which was summarized in Table 1. The average (SD) age in 
years upon entering was 74.9 (6.6) for the entire harmonized data, 72.8 (5.9) for the 
MoVIES study, and 77.3 (7.3) for the MYHAT study. The average (SD) age in years at 
the last follow-up was 81.4 (6.2) for the harmonized data, 80.9 (5.4) for the MoVIES 
study, and 82.1 (6.9) for the MYHAT study. The average (SD) follow-up time in years 
was 6.6 (4.1) for the harmonized data, 8.1 (4.4) for the MoVIES study, and 4.8 (2.9) for 
the MYHAT study. Note that the MYHAT study is on-going for a total of 9-10 years of 
data collection.  
 
Figure 2. Lexis-diagram 
 
There was a higher proportion of participants with less than high school (HS) 
education in MoVIES compared with that in MYHAT (42.4% vs. 11.1%). Moreover, 
participants in MoVIES had a higher average depression score compared with that of 
MYHAT (mean±SD mCESD score: 1.39±2.56 vs. 0.71±1.74). There were total 2,053 
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participants who had their ApoE4 allele expression checked. The percentage of ApoE4 
allele being positive in MoVIES and in MYHAT were very close (21.1% vs. 20.8%) and 
20.9% of all participants expressed ApoE4 allele. 
 
     Table 1. Data summary by study cohort 
           1Incident MCI = CDR = 0.5 
           *Abbreviation: HS = high school 
          2mCESD represents a modified version of the original Center for Epidemiologic Studies    
       Depression Scale (mCESD). 
 
Variable MoVIES 
(N=1,514) 
MYHAT 
(N=1,258) 
Total 
(N=2,772) 
 
Incident cases of MCI1  
 
305 
 
350 
 
655 
    
Incident rate of MCI 
Per 1,000 person-years 
24.9  57.4 35.7 
    
Age at baseline, in years    
N 1,514 1,258 2,722 
Mean (SD) 72.8 (5.9) 77.3 (7.3) 74.9 (6.6) 
 
Age at last follow-up, in years 
   
N 1,514 1,258 2,722 
Mean (SD) 80.9 (5.4) 82.1 (6.9) 81.4 (6.2) 
    
Follow time, years    
N 1,514 1,258 2,772 
Mean (SD) 8.1 (4.4) 4.8 (2.9) 6.6 (4.1) 
    
    
Female 902 (59.6%) 808 (64.2%) 1,710 (61.7%) 
    
APOE*4 allele, n (%)    
N 
Negative 
891 
703 (78.9%) 
1,162 
920 (79.2%) 
2,053 
1,623 (79.1%) 
Positive 188 (21.1%) 242 (20.8%) 430 (20.9%) 
    
Education n (%)    
< HS education 642 (42.4%) 140 (11.1%) 782 (28.2%) 
HS education  499 (33.0%) 575 (45.7%) 1,074 (38.7%) 
> HS education 373 (24.6%) 543 (43.2%) 916 (33.0%) 
    
mCESD score    
N 1,272 1,256 2,528 
Mean (SD) 1.39 (2.56) 0.71 (1.74) 1.05 (2.22) 
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The tabulated data in Table 2 and Table 3 show the age-specific MCI incidence 
rates for each calendar period and each birth cohort respectively. As we observed 
earlier from the lexis-diagram of Figure 2, there was a gap where there was no 
participant between the MoVIES study and the MYHAT study during the calendar period 
of 2002-2006. There were few three cases in the calendar period of 2000-2004. 
Considering the low incidence rate of MCI in period of 2000-2004 an artefact effect, we 
omitted this period in our following data analysis. We performed sensitivity analyses for 
data including this period and that excluding this period and the results were similar. In 
this thesis, we presented the analysis results that from data excluding this period. The 
charts in Figures 3 and 4 and the summarized age-specific MCI incidence rates in 
Tables 2 and 3 showed a trend within the same calendar period or the same birth 
cohort that the MCI incidence rates increase with age. For people within the same age 
group, the MCI incidence rates were higher in the calendar period 2005-2009 than that 
in other calendar periods (Figures 3 and 4, left panel), whereas no significant change 
in the MCI incidence rate was found among different birth cohorts (Figures 3 and 4, 
right panel). 
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Table 2. Age-specific MCI incident cases, follow-up person-years and rates by period 
  1985-1989 1990-1994 1995-1999 2000-2004 2005-2009 2010-2014 2015+ 
Incident Cases 
65-69 1 NA NA NA 9 NA NA 
70-74 6 12 NA NA 12 4 NA 
75-79 4 41 20 NA 23 17 1 
80-84 13 55 43 0 60 22 0 
85-89 6 31 33 2 64 43 1 
90-94 2 9 19 1 34 33 7 
95-99 NA 4 2 0 7 10 2 
100+ NA NA 1 0 1 0 0 
    Person-Years    
65-69 538.84 NA NA NA 310.88 NA NA 
70-74 817.36 1690.39 NA NA 593.15 471.93 NA 
75-79 498.39 2153.88 1262.09 NA 517.54 820.78 50.85 
80-84 258.48 1240.42 1403.28 327.36 618.38 658.88 63.41 
85-89 83.35 503.03 598.08 317.39 489.56 670.26 52.52 
90-94 9.05 150.42 186.55 120.67 167.64 423.46 43.17 
95-99 NA 19.21 32.01 25.20 18.95 89.73 22.87 
100+ NA NA 1.55 3.04 1.46 8.99 3.29 
      Rate      
65-69 1.86 NA NA NA 28.95 NA NA 
70-74 7.34 7.1 NA NA 20.23 8.48 NA 
75-79 8.03 19.04 15.85 NA 44.44 20.71 19.67 
80-84 50.29 44.34 30.64 0 97.03 33.39 0 
85-89 71.98 61.63 55.18 6.3 130.73 64.15 19.04 
90-94 220.96 59.83 101.85 8.29 202.81 77.93 162.14 
95-99 NA 208.23 62.49 0 369.37 111.45 87.44 
100+ NA NA 646.75 0 686.56 0 0 
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Table 3. Age-specific MCI incident cases, follow-up person-years and rates by cohort 
  1895-1899 1900-1904 1905-1909 1910-1914 1915-1919 1920-1924 1925-1929 1930-1934 1935-1939 1940+ 
 
65-69 NA NA NA NA NA 1 NA NA NA 9 
70-74 NA NA NA NA 6 12 NA NA 12 4 
75-79 NA NA NA 4 41 20 NA 23 17 1 
80-84 NA NA 13 55 43 NA 60 22 0 NA 
85-89 NA 6 31 33 NA 64 43 1 NA NA 
90-94 2 9 19 NA 34 33 7 NA NA NA 
95-99 4 2 NA 7 10 2 NA NA NA NA 
100+ 1 NA 1 0 0 NA NA NA NA NA 
   
Person years 
   69 NA NA NA NA NA 533.61 NA NA NA 310.88 
70-74 NA NA NA NA 817.36 1681.26 NA NA 593.15 471.93 
75-79 NA NA NA 498.39 2153.88 1257.09 NA 517.54 820.78 50.85 
80-84 NA NA 258.48 1240.42 1403.28 NA 618.38 658.88 63.41 NA 
85-89 NA 83.35 503.03 598.08 NA 489.56 670.26 52.52 NA NA 
90-94 9.05 150.42 186.55 NA 167.64 423.46 43.17 NA NA NA 
95-99 19.21 32.01 NA 18.95 89.73 22.87 NA NA NA NA 
100+ 1.55 NA 1.46 8.99 3.29 NA NA NA NA NA 
        Rate            
65-69 NA NA NA NA NA 1.87 NA NA NA 28.95 
70-74 NA NA NA NA 7.34 7.14 NA NA 20.23 8.48 
7579 NA NA NA 8.03 19.04 15.91 NA 44.44 20.71 19.67 
80-84 NA NA 50.29 44.34 30.64 NA 97.03 33.39 0 NA 
85-89 NA 71.98 61.63 55.18 NA 130.73 64.15 19.04 NA NA 
90-94 220.96 59.83 101.85 NA 202.81 77.93 162.14 NA NA NA 
95-99 208.23 62.49 NA 369.37 111.45 87.44 NA NA NA NA 
100+ 646.75 NA 686.56 0 0 NA NA NA NA NA 
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Figure 3. Age-specific MCI incidence rates by calendar period and birth cohorts  
Age-specific rates by calendar period (Left panel) and by birth cohort (Right panel).  
 
  
Figure 4. Period-specific and Cohort-specific MCI incidence rate by age 
 
Period-specific (Left panel) and Cohort-specific (Right panel) MCI incidence rates by age group.
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3.2 ESTIMATING MCI INCIDENCE RATES USING THE APC MODELLING 
APPROACH 
3.2.1  Single-factor APC models  
We first modelled the effects of age, period, and cohort using the traditional method by 
treating each temporal factor at a single-factor level. We observed that the incidence 
rates of MCI in the older participants (groups with age >= 80) were significantly higher 
than that in the younger-old participants. As shown in Table 4, the MCI incidence rates 
for age groups of 80-84 and 85-89 years were 3.8 and 6.3 times of that of the youngest  
 
Table 4. Poisson log-linear model with age effects only 
 
Estimate Std. Error z value Pr(>|z|) *RR p-value(a) 
(Intercept) -4.436 0.316 -14.029 0.000 1.0 
 A70-74 -0.216 0.360 -0.601 0.548 0.8 
 A75-79 0.524 0.331 1.585 0.113 1.7 
 A80-84 1.346 0.324 4.150 0.000 3.8 
 A85-89 1.836 0.325 5.650 0.000 6.3 
 A90-94 2.193 0.331 6.623 0.000 9.0 
 A95-99 2.447 0.374 6.539 0.000 11.6 <0.0001 
(a) P-value by likelihood ratio test (LRT) for all age groups 
*RR: Risk ration relative to the control group 
 
 
age group (age group of 65-69 which is control group). The MCI incidence rates for age 
groups of 90-94 and 95-99 years were 9.0 and 11.6 times of that of the youngest age 
group (age group of 65-69). We found that the MCI incidence rates increased gradually 
with time when comparing results from the earliest period, 1985-1989, through period 
2005-2009, and that the MCI incidence rates decreased starting from period 2010-2014 
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and remained stable afterwards (Table 5). We also found that the first birth cohort of 
1895-1899 had the highest MCI incidence rate. However, because participants in the 
first cohort were all aged at 90 or older, moreover, this earliest cohort only had total 
seven cases along with relatively short follow-up person-years (which could be seen in 
Table 3), the unusually high MCI incidence rate of the first cohort may not represent the 
true MCI incidence rate of that cohort. No clear pattern was observed for the change of 
MCI incidence rates among all the other cohorts (Table 6). 
 
Table 5. Poisson log-linear model with calendar period effects only 
 
Estimate Std. Error z value Pr(>|z|) RR* p-value(a) 
(Intercept) -4.231 0.177 -23.934 0.000 1.0 
 P1990-1994 0.598 0.194 3.074 0.002 1.8 
 P1995-1999 0.839 0.199 4.205 0.000 2.3 
 P2005-2009 1.666 0.190 8.777 0.000 5.3 
 P2010-2014 1.040 0.197 5.266 0.000 2.8 
 P2015+ 1.178 0.349 3.371 0.001 3.2 <0.0001 
(a) P-value by likelihood ratio test (LRT) for all period groups 
*RR: Risk ration relative to the control group 
 
 
Table 6. Poisson log-linear model with birth cohort effects only 
 
Estimate Std. Error z value Pr(>|z|) RR* p-value(a) 
(Intercept) -1.550 0.408 -3.796 0.000 1.0 
 C1900-1904 -1.200 0.475 -2.527 0.012 0.3 
 C1905-1909 -1.162 0.427 -2.719 0.007 0.3 
 C1910-1914 -1.620 0.420 -3.853 0.000 0.2 
 C1915-1919 -1.993 0.417 -4.776 0.000 0.1 
 C1920-1924 -1.959 0.417 -4.692 0.000 0.1 
 C1925-1929 -0.944 0.419 -2.252 0.024 0.4 
 C1930-1934 -1.736 0.434 -3.998 0.000 0.2 
 C1935-1939 -2.381 0.448 -5.309 0.000 0.1 
 C1940+ -2.537 0.488 -5.199 0.000 0.1 <0.0001 
(a) P-value by likelihood ratio test (LRT) for all birth cohorts 
*RR: Risk ration relative to the control group 
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3.2.2 Two-factor APC models  
We fit a two-factor model by including age and period but excluding birth cohort and the 
results are shown in Tables 7. After adjusting the period effect, compared to the single 
factor model with age only, age showed a more significant effect on the MCI incidence 
rate. As presented in Table 7, the incidence rates for age groups of 80-84 and 85-89 
years were 4.8 and 7.3 times of that of the youngest age group (age group of 65-69)  
respectively, while the incidence rates for age groups of 90-94 and 95-99 years were 
10.8 and 15.3 times of that of the youngest age group (age group of 65-69) respectively. 
The age effects we observed from this two-factor model with age and period are 
consistent with the findings from the single-factor model. However, after adjusting for 
age, we found that except for calendar period 2005-2009 all the other calendar periods 
do not have significantly higher MCI incident rate compared to the baseline period 1985-
1999, which is different from the results of the single-factor model.  
 
Table 7. Poisson log-linear model with age and period effects 
 
Estimate Std. Error z value Pr(>|z|) RR p-value(a) 
(Intercept) -4.916 0.338 -14.548 0.000 1.0 
 A70-74 -0.046 0.364 -0.126 0.899 1.0 
 A75-79 0.795 0.339 2.344 0.019 2.7 
 A80-84 1.569 0.333 4.713 0.000 4.8 
 A85-89 1.987 0.334 5.956 0.000 7.3 
 A90-94 2.382 0.341 6.980 0.000 10.8 
 A95-99 2.731 0.386 7.080 0.000 15.3 <0.0001 
P1990-1994 0.146 0.200 0.730 0.466 1.2 
 P1995-1999 -0.027 0.207 -0.131 0.896 1.0 
 P2005-2009 0.983 0.196 5.025 0.000 2.7 
 P2010-2014 0.077 0.207 0.374 0.708 1.1 
 P2015+ -0.076 0.358 -0.212 0.832 0.9 <0.0001 
(a) P-value by likelihood ratio test (LRT) for all age groups or all periods 
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Similarly, after adjusting for age in the analysis using the age-cohort two-factor 
model, although the entire cohorts still showed an overall significant effect on the MCI 
incidence rate based on the likelihood ratio test for all cohorts (p=0.01), we found no 
significant effect on the MCI incidence rate in any single birth cohort; see Table 8. 
These findings indicate that age is the most important temporal factor that affects the 
development of MCI. A model with period and cohort without including age may not 
make any sense at all, we did not fit the data into a two-factor model of period and 
cohort. 
Table 8. Poisson log-linear model with age and cohort effects 
 
Estimate Std. Error z value Pr(>|z|) RR p-value(a) 
(Intercept) -4.241 0.568 -7.461 0.000 1.0 
 A70-74 -0.073 0.374 -0.195 0.846 0.9 
 A75-79 0.783 0.372 2.107 0.035 2.2 
 A80-84 1.608 0.375 4.289 0.000 5.0 
 A85-89 2.049 0.373 5.500 0.000 7.8 
 A90-94 2.514 0.372 6.766 0.000 12.4 
 A95-99 2.765 0.423 6.541 0.000 15.9 <0.0001 
C1900-1994 -0.937 0.492 -1.903 0.057 0.4 
 C1905-1999 -0.539 0.460 -1.172 0.241 0.6 
 C1910-1914 -0.575 0.454 -1.268 0.205 0.6 
 C1915-1919 -0.540 0.444 -1.218 0.223 0.6 
 C1920-1924 -0.441 0.447 -0.985 0.325 0.6 
 C1925-1929 -0.144 0.455 -0.316 0.752 0.9 
 C1930-1934 -0.413 0.469 -0.881 0.378 0.7 
 C1935-1939 -0.280 0.485 -0.576 0.564 0.8 
 C1940+ 0.122 0.545 0.224 0.823 1.1 0.01 
(a) P-value by likelihood ratio test (LRT) for all age groups or all cohorts 
 
3.2.3 Constraint-based full APC model  
We analyzed the results with a constraint-based full APC model using the constraint 
cohort1 = cohort2 (i.e., C1895-1899 = C1900-1904) and the results show a clear trend 
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of significant increase in MCI incidence rates in the older-old population after controlling 
the effects of period and cohort; see Table 9. The finding observed in the constraint-
based full APC model confirmed the age effects that we have seen from the reduced 
one-factor model with age group only (Table 4) and two-factor model with age and 
period (Table 7). Moreover, based on the likelihood ratio test for all the calendar 
periods, the overall entire periods showed a significant effect on MCI incidence rate 
after adjusting for the effects of age and cohort (p<0.0001) although none of the single 
calendar period show a significant effect on MCI incidence rate after adjusting for the 
effects of age and cohort. It was observed that the MCI incidence rates was decreasing 
from period of 1990-1994 through 2015 after compared to the earliest period of 1985-
1989. No significant effect from either the entire cohorts or any single cohort was 
observed. 
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Table 9. Poisson log-linear model with age, period, and cohort effects*  
 
Estimate Std. Error z value Pr(>|z|) p-value(a) 
(Intercept) -9.107 2.149 -4.238 0.000 
 A70-74 1.128 0.650 1.736 0.083 
 A75-79 2.949 1.078 2.736 0.006 
 A80-84 4.544 1.544 2.943 0.003 
 A85-59 5.891 2.028 2.905 0.004 
 A90-95 7.276 2.518 2.890 0.004 
 A95-99 8.452 2.947 2.867 0.004 <0.0001 
P1990-1994 -0.786 0.532 -1.478 0.139 
 P1995-1999 -1.833 1.006 -1.822 0.069 
 P2005-2009 -2.649 1.986 -1.334 0.182 
 P2010-2014 -4.493 2.478 -1.813 0.070 
 P2015+ -5.594 2.981 -1.877 0.061 <0.0001 
C1905-1909 1.329 0.659 2.018 0.044 
 C1910-1914 2.153 1.136 1.896 0.058 
 C1915-1919 2.934 1.620 1.811 0.070 
 C1920-1924 3.804 2.106 1.806 0.071 
 C1925-1929 4.945 2.602 1.901 0.057 
 C1930-1934 5.647 3.099 1.822 0.068 
 C1935-1939 6.684 3.594 1.860 0.063 
 C1940+ 8.010 4.096 1.956 0.051 0.27 
*By constraint cohort1 = cohort2 (i.e. C1895-1899 = C1900-1904) 
(a) P-value by likelihood ratio test (LRT) for overall all age, overall calendar period, or overall birth cohort effects. 
 
 
 
We also chose the earliest two calendar periods as constraints to fit another 
constrain-based full APC model by letting period1=period2 (i.e., P1985-1989 = P1990-
1904) and the results are shown in Table 10. Note that Tables 9 and 10 showed similar 
results for the effects on trend of age, period, and cohort.  
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Table 10. Poisson log-linear model with age, period, and cohort effects* 
 
Estimate Std. Error z value Pr(>|z|) p-value(a) 
(Intercept) -5.178 1.228 -4.218 0.000 
 A70-74 0.342 0.444 0.772 0.440 
 A75-79 1.377 0.537 2.565 0.010 
 A80-84 2.187 0.673 3.249 0.001 
 A85-89 2.748 0.830 3.309 0.001 
 A90-94 3.348 1.013 3.304 0.001 
 A95-99 3.737 1.210 3.089 0.002 <0.0001 
P1995-1999 -0.261 0.260 -1.004 0.316 
 P2005-2009 0.494 0.645 0.766 0.444 
 P2010-2014 -0.564 0.842 -0.670 0.503 
 P2015+ -0.879 1.077 -0.816 0.414 <0.0001 
C1900-1904 -0.786 0.532 -1.478 0.139 
 C1905-1909 -0.243 0.606 -0.400 0.689 
 C1910-1914 -0.204 0.737 -0.277 0.782 
 C1915-1919 -0.209 0.897 -0.233 0.816 
 C1920-1924 -0.125 1.083 -0.115 0.908 
 C1925-1929 0.230 1.275 0.181 0.857 
 C1930-1934 0.147 1.464 0.100 0.920 
 C1935-1939 0.398 1.649 0.241 0.809 
 C1940+ 0.939 1.826 0.514 0.607 0.31 
*By constraint Period1 = Period2 (P1895-1899 = P1990-1994) 
(a) P-value by likelihood ratio test (LRT) for overall all age, overall calendar period, or overall birth cohort effects 
 
 
Thus far we observed that in the single-factor and two-factor models, age had the 
most pronounced effects on MCI incidence, therefore, we decided not to set constrains 
on the age effect. The earliest two calendar periods and the earliest two birth cohorts 
did not exhibit much difference and may be deemed to have equal effects. The results 
showed that the estimates under these two different constraint models were similar. 
Furthermore, the cohort equality constraints generate remarkably similar results to that 
from the reduced two-factor models. The results from the constraint-based full APC 
model on period and cohort effects are highly consistent with that of the two-factor 
models adjusting for age. 
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3.3 MODERATOR AND CONFOUNDER EFFECTS OF GENDER AND 
EDUCATION  
We examined the associations between gender and risk of MCI and found that the age-
specific MCI incidence rates for men and women were very close to each other; Figure 
5A. Similar trends were observed from the period-specific and cohort-specific rates; see 
Figures 5B and 5C.  
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Figure 5. Age-specific (A), Period-specific (B) and Birth-cohort-specific (C) MCI incidence rate by gender 
A C B 
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Further analysis with Poisson log-linear model stratified by gender demonstrated that 
gender did not play any significant role in moderating the effects of age, since none of 
the interaction terms (age*gender, period*gender, and cohort*gender) is significant; see 
Supplementary Tables 3-5. Gender either did not show any significant effect on the 
MCI incidence rates after adjusting for age, period, and cohort respectively; see 
Supplementary Tables 3.1, 4.1 and 5.1 respectively. 
Evidence regarding whether the trajectory of cognitive change in late life could be 
moderated by education remains conflicting. Early studies suggested that higher levels 
of education may help slow cognitive decline with aging [31-33]. In contrast, another 
longitudinal study reported that education does not help attenuate cognitive decline with 
aging [34]. In here we sought to examine whether education of the participants could 
have any impact in moderating the temporal effects on the development of MCI. Figure 
6A showed that participants receiving lower than HS education had significantly higher 
MCI incidence rates than those who had higher than HS education. After adjusting age, 
the MCI incidence rates for participants who received HS and higher than HS education 
were 0.92 (95% CI: 0.77-1.11, p=0.427) and 0.75 (95% CI: 0.61-0.92, p=0.005) times of 
those who had less than HS education respectively; see Table 11. Similar trend was 
observed in period-specific MCI incident rates of participants who received different 
level of education; see Figure 6B. The ratios of getting MCI for participants who 
received HS and higher than HS education over those who had less than HS education 
are 0.54 (95% CI: 0.46-0.67, p=0.000) and 0.42 (95% CI: 0.35-0.53, p=0.000) 
respectively after adjusting for period; see Table 13. Despite the observed effects of 
education on the MCI incidence rate, education does not moderate the effects of age or 
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period on MCI incidence rates while the interaction terms age*education and 
period*education did not show a significant effect in the Poisson log-linear model 
(Supplementary Tables 6 and 7).  
 
Table 11. Poisson log-linear model with age and education effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -4.306 0.323 -13.341 0.000 
A70-74 -0.222 0.360 -0.616 0.538 
A75-79 0.508 0.331 1.534 0.125 
A80-84 1.324 0.325 4.080 0.000 
A85-89 1.821 0.325 5.599 0.000 
A90-94 2.177 0.331 6.571 0.000 
A95-99 2.410 0.375 6.435 0.000 
Edugp1 *-0.074 0.093 -0.794 0.427 
Edugp2 #-0.284 0.100 -2.835 0.005 
*The ratio of getting MCI for participants received HS education is exp (-0.074) = 0.92 (95% CI: 0.77-1.11) 
times of those receiving less than HS education after adjusting for age effects. 
#The ratio of getting MCI for participants receiving more than HS education is exp (-0.284) = 0.75 (95% 
CI: 0.61-0.92) times of those receiving less than HS school education after adjusting for age effects. 
 
 
Table 12. Estimate of Age effects before and after adjusting for education.   
 
1Non-Adj. Est. 2Adj. Esti. *Change (%) 
(Intercept) -4.436 -4.306 2.93 
A70-74 -0.216 -0.222 2.78 
A75-79 0.524 0.508 3.05 
A80-84 1.346 1.324 1.63 
A85-89 1.836 1.821 0.82 
A90-94 2.193 2.177 0.73 
A95-99 2.447 2.410 1.51 
1Non-Adj. Est: Estimates obtained from the model without adjusting education 
2Adj. Est: Estimates obtained from the model after adjusting education 
*Change: means the change of coefficients before and after adjusting education = [(Adj. Est. – Non-Adj. 
Est.)/Non-Adj.Est] x 100% 
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Table 13. Poisson log-linear model with period and education effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -3.893 0.180 -21.592 0.000 
P1990-1994 0.613 0.195 3.146 0.002 
P1995-1999 0.909 0.200 4.545 0.000 
P2005-2009 1.934 0.194 9.959 0.000 
P2010-2014 1.313 0.204 6.449 0.000 
P2015+ 1.454 0.381 3.819 0.000 
edugp1 *-0.619 0.100 -6.218 0.000 
edugp2 #-0.871 0.109 -7.959 0.000 
*The ratio of getting MCI for participants receiving HS education is exp (-0.619) = 0.54 (95% CI: 0.46-
0.67) times of those receiving less than HS education after adjusting period.  
#The ratio of getting MCI for participants receiving more than HS is exp (-0.871) = 0.42 (95% CI: 0.35-
0.53) times of those receiving less than HS education after adjusting period. 
 
Table 14. Estimates of period effects before and after adjusting for education   
 
1Non-Adj. Est. 2Adj. Est. Change (%) 
(Intercept) -4.231 -3.893 7.75 
P1990-1994 0.598 0.613 6.20 
P1995-1999 0.839 0.909 8.60 
P2005-2009 1.666 1.934 16.80 
P2010-2014 1.040 1.313 29.10 
P2015+ 1.178 1.454 28.90 
1Non-Adj. Est: Estimates obtained from the model without adjusting education 
2Adj. Est: Estimates obtained from the model after adjusting education 
*Change: means the change of coefficients before and after adjusting education = [(Adj. Est. – Non-Adj. 
Est.)/Non-Adj.Est] x 100% 
 
 
The cohort-specific MCI incidence rates among participants with different 
education levels are depicted in Figure 6C. Different from the age-specific and period-
specific MCI incidence rates, a significant effect of interaction between cohort and 
education was found (Supplementary Table 8), which means that education level 
significantly moderates the impacts of birth cohort on the MCI incidence rates. There 
was not a clear monotone trend in cohort-specific MCI incidence rates among 
individuals receiving HS or higher than HS education  compared to those receiving 
lower than HS education, in other words, the cohort effect on MCI incidence rates was 
different depending on the education level. 
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      Figure 6. Age-specific (A), Period-specific (B) and Birth-cohort-specific (C) MCI incidence rate by education 
 
 
 
 
 
 
 
A B C 
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We then explored whether effects of age, period, and cohort on the MCI 
incidence rates were confounded by education. The estimated coefficients for age were 
compared before and after adjusting for education. If the percentage of the absolute 
change in the estimated coefficients is greater than 10%, we considered the effect of 
age as confounded. The percentage of change in coefficients before and after adjusting 
for education among age groups vary from 0.73% to 3.05 %, as shown in Table 12, 
indicating that the effect of age is not confounded by education. The percentage of 
change in coefficients before and after adjusting for education during periods 2005-
2009, 2010-2014, and 2015-after are 16.80%, 29.10%, and 28.90% respectively, as 
shown in Table 14, indicating that the effects of these three period groups are 
confounded by education. No confounding effect from education was observed on the 
cohort effects as the percentage of change in coefficients before and after adjusting 
education for birth cohorts varies from 0.9% to 8.9 %; see Table 15. 
 
Table 15. Estimate of cohort effects before and after adjusting for education   
 
1Non-Adj. Est. 2Adj. Est. Change (%) 
(Intercept) -1.550 -1.344 13.29 
C1900-1904 -1.200 --1.307 8.90 
C1905-1909 -1.162 -1.264 8.80 
C1910-1914 -1.620 -1.701 5.00 
C1915-1919 -1.993 -2.050 2.90 
C1920-1924 -1.959 -1.981 0.90 
C1925-1929 -0.944 -0.921 2.40 
C1930-1934 -1.736 -1.692 2.50 
C1935-1939 -2.381 -2.335 1.90 
C1940+ -2.537 -2.455 3.20 
1Non-Adj. Est: Estimates obtained from the model without adjusting education 
2Adj. Est: Estimates obtained from the model after adjusting education 
*Change: means the change of coefficients before and after adjusting education = [(Adj. Est. – Non-Adj. 
Est.)/Non-Adj.Est] x 100% 
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3.4  MODERATOR EFFECT OF APOE4 ALLELE  
We examined the impact of ApoE4 allele on moderating the effects of age, period, and 
cohort on the development of MCI. We modelled the MCI incidence rates with stratified 
data of ApoE4 allele expression. There was no significant effect from the interaction 
between age and ApoE4 allele on the age-specific MCI incidence rate; see 
Supplementary Table 9. No significant effect from the interaction terms between 
ApoE4 allele and period or cohort was observed when fitting the Poisson log-linear 
model with the stratified data of ApoE4 allele; see Supplementary Tables 10 and 11. 
These results show that in this study ApoE4 allele did not moderate the temporal effects 
on the development of MCI. 
Nonetheless, as shown in Figure 7A and Table 16, the age specific MCI rates 
were significantly higher in the participants expressing ApoE4 allele than those non-
ApoE4 allele expressing participants (p=0.012). The average rate of ApoE4 allele 
positive patients getting MCI is 1.29 (95% CI: 1.05-1.57) times of that for ApoE4 allele 
negative participants after adjusting age. Marginal effects of ApoE4 allele on the period 
specific MCI incident rate (Figure 7B and Table 17) and the cohort specific MCI 
incident rate (Figure 7C and Table 18) were observed.  
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Table 16. Poisson log-linear model with age and APOE4 effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -4.278 0.318 -13.473 0.000 
A70-74 -0.575 0.376 -1.529 0.126 
A75-79 0.275 0.334 0.823 0.411 
A80-84 1.108 0.326 3.395 0.001 
A85-89 1.594 0.327 4.875 0.000 
A90-94 2.002 0.333 6.003 0.000 
A95-99 2.232 0.385 5.804 0.000 
Allele *0.256 0.103 2.498 0.012 
*The ratio of getting MCI for APOE positive participants is exp (0.256) = 1.29 (95% CI: 1.05-1.57, 
p=0.012) times of those APOE negative after adjusted for age. 
 
Table 17. Poisson log-linear model with calendar period and APOE4 effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -4.903 0.317 -15.452 0.000 
P1990-1994 1.026 0.333 3.080 0.002 
P1995-1999 1.445 0.331 4.371 0.000 
P2005-2009 2.269 0.324 6.992 0.000 
P2010-2014 1.686 0.329 5.125 0.000 
P2015+ 1.896 0.437 4.339 0.000 
Allele *0.184 0.102 1.798 0.072 
*The ratio of getting MCI for APOE4 carriers is exp (0.184) =1.20 (95% CI: 0.98-1.46) times higher than 
those non-APOE*4 carriers after adjusting for period. 
 
Table 18. Poisson log-linear model with birth cohort and APOE4 effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -2.432 1.000 -2.432 0.015 
C1900-1904 -0.324 1.070 -0.303 0.762 
C1905-1909 -0.315 1.013 -0.311 0.756 
C1910-1914 -0.766 1.007 -0.761 0.447 
C1915-1919 -1.130 1.005 -1.125 0.261 
C1920-1924 -1.116 1.005 -1.111 0.267 
C1925-1929 -0.079 1.005 -0.078 0.938 
C1930-1934 -0.837 1.012 -0.828 0.408 
C1935-1939 -1.613 1.020 -1.581 0.114 
C1940+ -1.726 1.038 -1.662 0.096 
Allele *0.185 0.102 1.805 0.071 
*The ratio of getting MCI for APOE*4 carriers is exp (0.185) =1.20 (95% CI: 0.98-1.47) times higher than 
that of non-APOE*4 carriers after adjusting for cohort. 
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         Figure 7. Age-specific (A), Period-specific (B) and Birth-cohort-specific (C) MCI incidence rate by ApoE4 allele 
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3.5  MODERATOR EFFECTS OF STUDY  
We examined whether there was a difference in the MCI incidence rates between the 
MYHAT and the MoVIES studies. The MCI incidence rate in the MYHAT study cohort, 
as shown in Figure 8, were consistently higher than in the MoVIES study for all age 
groups. We checked the interaction between age and study with Poisson log linear 
model to see if the age effect on MCI incidence rates was moderated and found that the 
study did not moderate the age effect since the interaction of age*study was not 
significant (p=0.13); see Supplementary Table 12. We did find a significant difference 
in age-specific MCI incidence rates between MoVIES and MYHAT (p <0.001) after 
dropping the interaction term from our model: the ratio of getting MCI for the MYHAT 
participants was 1.62 (95% CI: 1.38-1.90) times of that for the MoVIES participants after 
adjusting for age; see Table 19.  
 
Table 19. Poisson log-linear model with age and study effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -4.641 0.319 -14.562 0.000 
A70-74 -0.180 0.360 -0.502 0.616 
A75-79 0.579 0.331 1.750 0.080 
A80-84 1.372 0.324 4.232 0.000 
A85-89 1.769 0.325 5.440 0.000 
A90-94 2.061 0.332 6.212 0.000 
A95-99 2.284 0.375 6.088 0.000 
Study *0.482 0.082 5.859 0.000 
*The ratio of getting MCI for patients in MYHAT study is exp (0.48) = 1.62 (95% CI: 1.38-1.90, p=0.000) 
times of patients in MOVIES study after adjusting for age group. 
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Figure 8. Age-specific MCI incidence rates by study 
3.6  EVALUATION OF MODEL FITNESS 
For each of the model used in the study, the Akaike information criterion (AIC) is listed 
in Table 20. The model with age and period has the smallest AIC value. The constraint-
base full APC model has the second smallest AIC value that is very close to the AIC 
value of model with age and period. To select the appropriate model, we compared the 
coefficients of age, period and cohort from different models, including the reduced two-
factor and full APC models, it is of note that all the coefficients for these 3 time-related 
factors age, period and cohort changed quite a lot among different models that means 
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the effects of these 3 factors could be confounded by each other. Given such a 
situation, all 3 time related factors should be included into the model. Education was a 
confounder of period effect on the MCI incidence rate and thus was considered being 
included in the analysis model. However, when fitting the data into the Poisson log-
linear model with age, period, cohort and education, we found a much larger AIC value 
(444.0) compared to the full APC models without including education. As the education 
is not a confounder of age effect but period effect only, and age is the most important 
influence factor of MCI incidence rate. Moreover, education moderated the cohort 
effects, but we cannot put that many interaction terms into the model with our current 
sample size. Taken all together, we chose the constraint-based full APC model with 
period1=period2 or cohort1=cohort2 as constraints for our current data to investigate 
the independent effects of temporal factors on the MCI incidence rates. 
 
Table 20. AIC of Different models 
Model AIC 
Age 292.3 
Period 502.5 
Cohort 529.6 
Age+Period 196.1 
Age+Cohort 289.1 
Age+period+cohort (P1=P2) 201.2 
Age+period+cohort (C1=C2) 202.2 
Age+Period+Cohort+Education 444.0 
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4.0  DISCUSSION 
In this study, by using the APC modelling approach, we examined the temporal changes 
in MCI incidence rates in the senior population (>= 65 years old) recruited to the 
community-based cohort studies from Year 1985 to 2008. We observed that much of 
the rise in MCI incidence rates was driven by an age effect. Overall, within the same 
calendar period and the same birth cohort, the MCI incidence rate was monotonically 
increasing in age. This finding is consistent with those reported in the recent literatures 
[35-37].  
We also found that among those who are within the same age group and within 
the same birth cohort, calendar period of 2005-2009 showed a significantly increased 
MCI incidence rate compared to other calendar periods. A possible reason leading to an 
increased MCI rate in 2005-2009 might be that the recruitment criteria and the 
frequency of the outcome assessments for the two study cohorts are different. For the 
MoVIES study, participants needed to have at least Grade 6 education to be eligible for 
recruitment. For the MYHAT study, individuals having Mini Mental State Examination 
(MMSE) score <21 were not eligible. At study baseline, 43.3% of MoVIES and 13.8% of 
MYHAT participants had less than HS education and their averaged ages were 72.8 ± 
5.9 and 77.3 ± 7.3 years old, respectively. The assessments for participants recruited 
into MoVIES were done approximately once every two years while the participants in 
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MYHAT were done annually. We suspected that with a higher education level and 5 
years older in averaged age, MYHAT participants may contain higher percentage of 
MCI prevalent cases (false negative for MCI at baseline). Therefore, the incidence rate 
of MCI in 2005-2009 was much higher compared to other calendar time periods. For the 
effect of birth cohort, none of the birth cohorts showed a significant effect on the MCI 
incident rates after adjusting for both age and period. Our study was the first study that 
examined the effects of age, calendar period, and birth cohort simultaneously on the 
MCI incidence rates using the APC modelling strategy.  
Besides exploring the time trends in MCI incidence rates, we studied the 
underlying factors that could moderate or confound the effects of age, period, and 
cohort on the development of MCI. No apparent moderating effect of gender was 
observed on the development of MCI incident rates. The factors we investigated 
included gender, education, and ApoE4 allele.  
Education played a complicated role in the development of MCI. For the same 
age group, participants receiving higher than HS education had significantly lower MCI 
incidence rate. However, the age effect on MCI incidence rate was not moderated or 
confounded by education. Our study found that, on the other hand, the period effects 
and cohort effects were significantly confounded and moderated by education, 
respectively. The effects of the latest 3 periods of 2005-2009, 2010-2014 and 2015 
after, especially periods 2010-2014 and 2015 after were significantly confounded by 
education. It indicates that higher education is both associated with later time period 
and with lower MCI incidence rate. This also explains the overall trend of MCI incidence 
rate is decreasing throughout the observation periods of this study after adjusting the 
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effects of age and cohort. Education moderated the cohort effects on MCI incidence 
rates, the cohorts receiving HS education showed an increasing trend in MCI incidence 
rates compared to control, whereas the birth cohorts receiving higher than HS education 
did not show a significant change compared to the control. 
Our study confirmed that genetic factor, ApoE4 allele, is a risk factor in the 
development of MCI, which is consistent with literatures [4, 5]. We found that, except 
the youngest and the oldest age groups, the MCI incident rates were significantly and 
consistently higher in the ApoE4 allele positive population than the ApoE4 allele 
negative population within the same age group. As mentioned earlier, participants in the 
youngest and oldest age groups are fewer, therefore, the data from these participants 
might not predict the true MCI incidence rates in these subpopulations. We concluded 
that ApoE4 could mediate the decline of cognitive functions, which agreed with the 
previous reports [38, 39]. 
Besides the aforementioned findings, however, our study also has some 
limitations. There was a 5-year gap, approximately, between MoVIES and MYHAT data, 
which made the follow-up time not continuous. There was a low number of participants 
and few MCI cases in the period of 2000-2004, which resulted in an unusually low MCI 
incidence rate in this period. , We performed a sensitivity analysis by fitting the data into 
Poisson log-linear model with or without period of 2000-2004 and yield the same 
results, therefore, we removed the period of 2000-2004 in our analysis. Moreover, there 
were some other groups or periods (the youngest age-group, the earliest period group, 
and birth cohort) with low number of participants, which may have prevented us to find 
additional associations. Thus far it is not well documented about which statistical 
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package(s) could be used to efficiently handle the APC model with unequal age, period, 
or cohort intervals.  
Despite these limitations, this study has several strengths. First, our study was 
the first time to apply the APC model analysis to study MCI incidence rates. By using 
this model, we estimated the contributions of age, period, and birth cohort to MCI 
incidence rates simultaneously. Second, the data used in our study was from a large 
population, with a long follow-up time span, which allow us to estimate the calendar 
period effects well. Using the APC model, our studies confirmed the effects of multiple 
factors, e.g., demographic (e.g. age, education) and genetic (e.g. ApoE4 allele) factors, 
on the development of MCI.  
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APPENDIX A: R CODES FOR ANALYSIS 
#-------Thesis Data Part (I) Primary analysis------------------#                  
 
library(sas7bdat) 
library(Epi) 
library(ggplot2) 
library(plyr) 
library(gridExtra) 
library(lmtest) 
 
#---------------------------------------------------------------------------# 
# Data pre-processing 
#---------------------------------------------------------------------------# 
mydata<- read.sas7bdat("plot3.sas7bdat") 
dim(mydata)#3021 
mydata<-mydata[which(!is.na(mydata$CASE)),] 
dim(mydata)#3021 
 
Lex.raw<-structure( 
list(id=mydata$researchid, 
        birth=as.Date(as.character(format(as.Date(mydata$DTBIR,origin="1960-01-01"),'%d/%m/%Y')),'%d/%m/%Y'), 
INTDT1= as.Date(as.character(format(as.Date(mydata$intdt1,origin="1960-01-01"),'%d/%m/%Y')),'%d/%m/%Y'), 
LTFUDT= as.Date(as.character(format(as.Date(mydata$LTFUDT,origin="1960-01-01"),'%d/%m/%Y')),'%d/%m/%Y'), 
fail=mydata$CASE, 
ageIn=mydata$AGE1, 
allele=mydata$allele, 
study=mydata$STUDY), 
.Names=c("id","DOB","INTDT1","LTFUDT","fail","ageIn","allele","study"), 
row.names=as.character(mydata$researchid), 
class='data.frame') 
Lex.raw$en <- cal.yr( Lex.raw$INTDT1, format="%Y-%m-%d" ) 
Lex.raw$ex <- cal.yr( Lex.raw$LTFUDT , format="%Y-%m-%d" ) 
Lex.raw$bt <- cal.yr( Lex.raw$DOB , format="%Y-%m-%d" ) 
 
#---------------------------------------------------------------------------# 
# Convert data.frame to a Lexis project 
#---------------------------------------------------------------------------# 
Lex.data<-Lexis(entry=list(per=en,age=en-bt,dob=bt), 
exit=list(per=ex), 
exit.status=fail, 
data=Lex.raw) 
 
#---------------------------------------------------------------------------# 
# Figure 2: Lexis-diagram (each line represents one person, each blob       #        # represents an event/case, beginning of the line 
represents # the entry date # while the end represents the last follow-up date).  
#---------------------------------------------------------------------------# 
png("Figure1 Lexsis Diagram.png",width=800,height=800,res=100) 
     plot(Lex.data,time.scale=c("per","age"),grid=0:20*5, 
col="black",xaxs="i",yaxs="i",xlim=c(1980,2020),las=1, 
ylab="Age at entry",xlab="Year of entry") 
points( Lex.data, time.scale=c("per","age"),pch=c(NA,16)[Lex.data$lex.Xst+1], col="red", cex=1 ) 
 
dev.off() 
#---------------------------------------------------------------------------# # Function to split data 
#---------------------------------------------------------------------------# 
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acpSplit<-function(indata,age.breaks,per.breaks,birth.breaks){ 
 
split.data1 <- splitLexis( indata, breaks = age.breaks, time.scale="age" ) 
split.data <- splitLexis( split.data1, breaks =per.breaks, time.scale="per") 
split.data$Per_F<-timeBand(split.data,"per","left") 
split.data$Age_F<-ncut(split.data$age,age.breaks,type="left") 
split.data$Birth_F<-split.data$Per_F-split.data$Age_F 
split.data$Birth_F0<-ncut(split.data$bt,birth.breaks,type="left") 
index.l<-which(split.data$Birth_F>split.data$Birth_F0) 
split.data$Age_F[index.l]<-split.data$Age_F[index.l]+5 
split.data$Birth_F<-split.data$Per_F-split.data$Age_F 
temp.data<-dply(split.data, 
.(Age_F,Per_F,Birth_F), 
summarize,D=sum(lex.Xst), 
Y=sum(lex.dur), 
Rate=sum(lex.Xst)/sum(lex.dur)) 
return(list(split.data=split.data,Data=temp.data)) 
 
} 
#---------------------------------------------------------------------------# 
# Splitting the data 
#---------------------------------------------------------------------------# 
Lex.data<-Lex.data[which(Lex.data$age>=65),] 
res1<-
acpSplit(indata=Lex.data,age.breaks=seq(65,105,by=5),per.breaks=seq(1985,2020,by=5),birth.breaks=seq(1895,1945,by
=5)) 
 
#---------------------------------------------------------------------------# 
# Figure.3 Age-specific MCI incidence rate (per 1,000 person-years) by #      # calendar period and by birth cohort.  
# Left panel: Age-specific rates by calendar period. Right panel:          # # Age-specific rates by birth cohorts. (left panel) 
#---------------------------------------------------------------------------# 
temp.data<-na.omit(ddply(res1$split.data,.(Age_F,Per_F,Birth_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age_F<100,] 
Figure2<-ggplot(data = temp.data,aes(x = Age_F, y = Rate*10^3,color=factor(Per_F))) + 
geom_line(lwd=1.5)+ 
geom_point(size=3)+ 
xlab("Age") + ylab("MCI Rate Per 1000") + 
ggtitle("Age-Specific MCI Incidence Rate by Time Period") + 
theme_bw() + 
geom_hline(yintercept=seq(0,400,by=50),lty="dashed",colour="black") + 
theme(legend.justification=c(0,1), 
legend.position=c(0,1), 
legend.background=element_blank(), 
panel.grid.major = element_blank(), 
panel.grid.minor = element_blank(), 
axis.line = element_line(colour = "black",size=1), 
legend.title=element_text(colour="blue",size=10,face="bold"), 
legend.text=element_text(colour="black",size=10,face="bold"), 
legend.key=element_blank(), 
axis.title = element_text(colour="black",size=15,face="bold"), 
axis.text = element_text(colour="black", size=12,face="bold"), 
plot.title=element_text(colour="black",  size=16,face="bold")) + 
scale_colour_discrete(name = "Period",labels=c("1985-89","1990-94","1995-99","2000-04","2005-
09","2010-14","2015 +")) + 
scale_x_continuous(breaks=c(65,70,75,80,85,90,95),labels=c("65-69", "70-74","75-79","80-84","85-89","90-94","95-99")) + 
scale_y_continuous(breaks=seq(0,400,by=50)) 
 
png("Figure2_5_all Age-Specific MCI Incidence Rate by Time Period.png",width=800,height=800,res=100) 
Figure2 
dev.off() 
 
#---------------------------------------------------------------------------# 
# Figure.3 Age-specific MCI incidence rate (per 1,000 person-years)                     # bycalendar period and by birth cohort.  
# Left panel: Age-specific rates by calendar period. Right panel:  
# Age-specific rates by birth cohorts. (right panel) 
#---------------------------------------------------------------------------# 
temp.data<-na.omit(ddply(res1$split.data,.(Age_F,Birth_F,Per_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age<100,] 
Figure3<-ggplot(data = temp.data,aes(x = Age_F, y = Rate*10^3,color=factor(Birth_F))) + 
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geom_line(lwd=1.5)+ 
geom_point(size=3)+ 
xlab("Age") + ylab("MCI Rate Per 1000") + 
ggtitle("Age-Specific MCI Incidence Rate by Birth Cohort") + 
theme_bw() + 
geom_hline(yintercept=seq(0,400,by=50),lty="dashed",colour="black") + 
theme(legend.justification=c(0,1), 
legend.position=c(0,1), 
legend.background=element_blank(), 
panel.grid.major = element_blank(), 
panel.grid.minor = element_blank(), 
axis.line = element_line(colour = "black",size=1), 
legend.title=element_text(colour="blue",size=10,face="bold"), 
legend.text=element_text(colour="black",size=10,face="bold"), 
legend.key=element_blank(), 
axis.title = element_text(colour="black",size=15,face="bold"), 
axis.text = element_text(colour="black", size=12,face="bold"), 
plot.title=element_text(colour="black",  size=16,face="bold")) + 
scale_colour_discrete(name = "Birth",labels=c("1895-99","1900-04","1905-09","1910-14","1915-19","1920-24","1925-29", 
"1930-34","1935-39","1940 +")) + 
scale_x_continuous(breaks=c(65,70,75,80,85,90,95), 
labels=c("65-69", "70-74","75-79","80-84","85-89","90-94","95-99")) + 
scale_y_continuous(breaks=seq(0,400,by=50)) 
 
png("Figure3_5_all Age-Specific MCI Incidence Rate by Birth Cohort.png",width=800,height=800,res=100) 
Figure3 
dev.off() 
 
#---------------------------------------------------------------------------# 
# Figure 4: Period-specific MCI incidence rate (per 1,000 person-years) by #age and Cohort-specific incidence rate by age. Left  # #  
panel: Period-# # # specific rates by age groups. Right panel: Cohort-specific rates by age # # # groups. (left panel) 
#---------------------------------------------------------------------------# 
temp.data<-na.omit(ddply(res1$split.data,.(Per_F,Age_F,Birth_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age_F<100,] 
Figure4<-ggplot(data = temp.data,aes(x = Per_F, y = Rate*10^3,color=factor(Age_F))) + 
geom_line(lwd=1.5)+ 
geom_point(size=3)+ 
xlab("Period") + ylab("MCI Rate Per 1000") + 
ggtitle("Period-Specific MCI Incidence Rate by Age Group") + 
theme_bw() + 
geom_hline(yintercept=seq(0,400,by=50),lty="dashed",colour="black") + 
theme(legend.justification=c(0,1), 
legend.position=c(0,1), 
legend.background=element_blank(), 
panel.grid.major = element_blank(), 
panel.grid.minor = element_blank(), 
axis.line = element_line(colour = "black",size=1), 
legend.title=element_text(colour="blue",size=10,face="bold"), 
legend.text=element_text(colour="black",size=10,face="bold"), 
legend.key=element_blank(), 
axis.title = element_text(colour="black",size=15,face="bold"), 
axis.text = element_text(colour="black", size=12,face="bold"), 
plot.title=element_text(colour="black",  size=16,face="bold"), 
axis.text.x = element_text(angle=45,hjust=1)) + 
scale_colour_discrete(name = "Age",labels=c("65-69", "70-74","75-79","80-84","85-84","90-94","95-99")) + 
scale_x_continuous(breaks=c(1985,1990,1995,2000,2005,2010,2015),labels=c("1985-89","1990-94","1995-
99","2000-04","2005-09","2010-14","2015 +")) + 
scale_y_continuous(breaks=seq(0,400,by=50)) 
 
png("Figure4_5_all Period-Specific MCI Incidence Rate by Age Group.png",width=800,height=800,res=100) 
Figure4 
dev.off() 
 
#---------------------------------------------------------------------------# 
# Figure 4: Period-specific MCI incidence rate (per 1,000 person-years) by #age and Cohort-specific incidence rate by age. Left   
# # panel: Period-specific rates by age groups. Right panel: Cohort-specific # rates by age groups. (right panel) 
#---------------------------------------------------------------------------# 
temp.data<-na.omit(ddply(res1$split.data,.(Birth_F,Age_F,Per_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age_F<100,] 
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Figure5<-ggplot(data = temp.data,aes(x = Birth_F, y = Rate*10^3,color=factor(Age_F))) + 
geom_line(lwd=1.5)+ 
geom_point(size=3)+ 
xlab("Birth") + ylab("MCI Rate Per 1000") + 
ggtitle("Birth Cohort-Specific MCI Incidence Rate by Age groups") + 
theme_bw() + 
geom_hline(yintercept=seq(0,400,by=50),lty="dashed",colour="black") + 
theme(legend.justification=c(0,1), 
legend.position=c(0,1), 
legend.background=element_blank(), 
panel.grid.major = element_blank(), 
panel.grid.minor = element_blank(), 
axis.line = element_line(colour = "black",size=1), 
legend.title=element_text(colour="blue",size=10,face="bold"), 
legend.text=element_text(colour="black",size=10,face="bold"), 
legend.key=element_blank(), 
axis.title = element_text(colour="black",size=15,face="bold"), 
axis.text = element_text(colour="black", size=12,face="bold"), 
plot.title=element_text(colour="black",  size=16,face="bold"), 
axis.text.x = element_text(angle=45,hjust=1) 
 
) + 
scale_colour_discrete(name = "Age",labels=c("65-69", "70-74","75-79","80-84","85-89","90-94","95-99")) + 
scale_x_continuous(breaks=c(1895,1900,1905,1910,1915,1920,1925,1930,1935,1940), 
labels=c("1895-99","1900-04","1905-09","1910-14","1915-19","1920-24","1925-29", 
"1930-34","1935-39","1940 +")) + 
scale_y_continuous(breaks=seq(0,400,by=50)) 
 
png("Figure5_5_all Birth-Specific MCI Incidence Rate by Age Group.png",width=800,height=800,res=100) 
Figure5 
dev.off() 
 
#Table 11 Poisson log-linear model with age, calendar period, and birth #cohort effects# 
n.a<-length(unique(as.character(temp.data2$A)))#4 number of age groups 
n.p<-length(unique(as.character(temp.data2$P)))#10 number of period groups 
n.c<-length(unique(as.character(temp.data2$C)))#4 number of cohort groups 
 
#------Contrast matrix for CGLIM 3 (C1=C2) 
con.t<-contr.treatment(n.c,base=1) 
con.c<-con.t 
con.c[2,1]<-0 
con.a<-contr.treatment(n.a,base=1) 
con.p<-contr.treatment(n.p,base=1) 
fit.f.apc <- glm(D ~ A+ P+ C+ offset(log(Y)),data=temp.data2,              
                 family = quasi(link = log,var="mu"),  
                 control = glm.control(epsilon = 1e-010, maxit = 10),  
                 contrasts= list(A=con.a,P=con.p,C=con.c),intercept = intercept) 
 
write.csv(coef(summary(fit.f.apc)),"model_5_APC_all_C1=C2.csv") 
 
anova(fit.f.apc,test="Chisq") 
 
 
#Table 12 Poisson log-linear model with age, calendar period, and birth #cohort effects 
n.a<-length(unique(as.character(temp.data2$A)))#4 number of age groups 
n.p<-length(unique(as.character(temp.data2$P)))#10 number of period groups 
n.c<-length(unique(as.character(temp.data2$C)))#4 number of cohort groups 
 
#------Contrast matrix for CGLIM 3 (P1=P2) 
con.t<-contr.treatment(n.p,base=1) 
con.p<-con.t 
con.p[2,1]<-0 
con.a<-contr.treatment(n.a,base=1) 
con.c<-contr.treatment(n.c,base=1) 
fit.f.apc <- glm(D ~ A+ P+ C+ offset(log(Y)),data=temp.data2,              
                 family = quasi(link = log,var="mu"),  
                 control = glm.control(epsilon = 1e-010, maxit = 10),  
                 contrasts= list(A=con.a,P=con.p,C=con.c),intercept = intercept) 
 
write.csv(coef(summary(fit.f.apc)),"model_5_APC_all_P1=P2.csv") 
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anova(fit.f.apc,test="Chisq") 
 
 
#---Thesis Data   Part (II) interaction with gender----#                                                                              
#  Figure 5 
Lex.data<-Lex.data[which(Lex.data$age>=65),] 
res<-
acpSplit(indata=Lex.data,age.breaks=seq(65,105,by=5),per.breaks=seq(1985,2020,by=5),birth.breaks=seq(1895,1945,by
=5)) 
 
 
temp.data<-na.omit(ddply(res$split.data,.(sexf,Age_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age_F<95,] 
P_age<-ggplot(data = temp.data,aes(x = Age_F, y = Rate*10^3,color=factor(sexf))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Age") + ylab("MCI Rate Per 1000") + 
  ggtitle("Age-Specific MCI Incidence Rate by Gender") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,120,by=20),lty="dashed",colour="black") + 
  theme(legend.justification=c(0,1),  
        legend.position=c(0,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=10,face="bold"), 
        legend.text=element_text(colour="black",size=10,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold")) + 
   
  scale_colour_discrete(name = "",labels=c("Male","Female")) + 
  scale_x_continuous(breaks=c(65,70,75,80,85,90,95), 
                     labels=c("65-69", "70-74","75-79","80-84","85-89","90-94","95-99")) + 
scale_y_continuous(breaks=seq(0,120,by=20)) 
 
png("Figure1_5_Age-Specific MCI Incidence Rate by Gender.png",width=800,height=800,res=100) 
P_age 
dev.off() 
 
# Figure 6 
temp.data<-na.omit(ddply(res$split.data,.(sexf,Per_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
 
P_period<-ggplot(data = temp.data,aes(x = Per_F, y = Rate*10^3,color=factor(sexf))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Period") + ylab("MCI Rate Per 1000") + 
  ggtitle("Period-Specific MCI Incidence Rate by Gender") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,80,by=20),lty="dashed",colour="black") + 
  theme(legend.justification=c(0,0.9),  
        legend.position=c(0,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=10,face="bold"), 
        legend.text=element_text(colour="black",size=10,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold"), 
        axis.text.x = element_text(angle=45,hjust=1) 
         
  ) + 
   
  scale_colour_discrete(name = "",labels=c("Male","Female")) + 
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  scale_x_continuous(breaks=c(1985,1990,1995,2000,2005,2010,2015), 
                     labels=c("1985-89","1990-94","1995-99","2000-04","2005-09","2010-14","2015 +")) + 
  scale_y_continuous(breaks=seq(0,80,by=20)) 
png("Figure1_5_Period-Specific MCI Incidence Rate by gender.png",width=800,height=800,res=100) 
P_period 
dev.off() 
 
#-----Figure 7----# 
 
temp.data<-na.omit(ddply(res$split.data,.(sexf,Birth_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
 
P_cohort<-ggplot(data = temp.data,aes(x = Birth_F, y = Rate*10^3,color=factor(sexf))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Birth Cohort") + ylab("MCI Rate Per 1000") + 
  ggtitle("Birth Cohort-Specific MCI Incidence Rate by Gender") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,300,by=50),lty="dashed",colour="black") + 
  theme(legend.justification=c(0.9,1),  
        legend.position=c(0.9,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=12,face="bold"), 
        legend.text=element_text(colour="black",size=12,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold"), 
        axis.text.x = element_text(angle=45,hjust=1) 
         
  ) + 
   
  scale_colour_discrete(name = "",labels=c("Male","Female")) + 
  scale_x_continuous(breaks=c(1895,1900,1905,1910,1915,1920,1925,1930,1935,1940), 
labels=c("1895-99","1900-04","1905-09","1910-14","1915-19","1920-24","1925-29", 
                              "1930-34","1935-39","1940 +")) + 
  scale_y_continuous(breaks=seq(0,300,by=50)) 
 
png("Figure1_5_Cohort-Specific MCI Incidence Rate by gender.png",width=800,height=800,res=100) 
P_cohort 
dev.off() 
 
#-----Thesis Data   Part (III) interaction with education-------------#                                                                            
#-----Figure 9. Age-specific MCI incidence rate by education level----# 
 
Lex.data<-Lex.data[which(Lex.data$age>=65),] 
res<-
acpSplit(indata=Lex.data,age.breaks=seq(65,105,by=5),per.breaks=seq(1985,2020,by=5),birth.breaks=seq(1895,1945,by
=5)) 
 
temp.data<-na.omit(ddply(res$split.data,.(edugp,Age_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age_F<95,] 
P_age<-ggplot(data = temp.data,aes(x = Age_F, y = Rate*10^3,color=factor(edugp))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Age") + ylab("MCI Rate Per 1000") + 
  ggtitle("Age-Specific MCI Incidence Rate by Education Level") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,120,by=20),lty="dashed",colour="black") + 
  theme(legend.justification=c(0,1),  
        legend.position=c(0,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=10,face="bold"), 
        legend.text=element_text(colour="black",size=10,face="bold"), 
        legend.key=element_blank(), 
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        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold") 
  ) + 
   
  scale_colour_discrete(name = "",labels=c("<High School","High School",">High School")) + 
  scale_x_continuous(breaks=c(65,70,75,80,85,90,95), 
                     labels=c("65-69", "70-74","75-79","80-84","85-89","90-94","95-99")) + 
  scale_y_continuous(breaks=seq(0,120,by=20)) 
 
png("Figure1_5_Age-Specific MCI Incidence Rate by education.png",width=800,height=800,res=100) 
P_age 
dev.off() 
 
#----Figure 10. Period-specific MCI incidence rate by education levels---# 
 
temp.data<-na.omit(ddply(res$split.data,.(edugp,Per_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
 
P_period<-ggplot(data = temp.data,aes(x = Per_F, y = Rate*10^3,color=factor(edugp))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Period") + ylab("MCI Rate Per 1000") + 
  ggtitle("Period-Specific MCI Incidence Rate by Education Level") + theme_bw() + 
  geom_hline(yintercept=seq(0,150,by=30),lty="dashed",colour="black") + 
  theme(legend.justification=c(0,0.9),  
        legend.position=c(0,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=10,face="bold"), 
        legend.text=element_text(colour="black",size=10,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold"), 
        axis.text.x = element_text(angle=45,hjust=1) 
         
  ) + 
   
  scale_colour_discrete(name = "",labels=c("<High School","High School",">High School")) + 
  scale_x_continuous(breaks=c(1985,1990,1995,2000,2005,2010,2015), 
                     labels=c("1985-89","1990-94","1995-99","2000-04","2005-09","2010-14","2015 +")) + 
  scale_y_continuous(breaks=seq(0,150,by=30)) 
png("Figure1_5_Period-Specific MCI Incidence Rate by education.png",width=800,height=800,res=100) 
P_period 
dev.off() 
 
#---Figure 11. Cohort-specific MCI incidence rate by education levels---# 
 
temp.data<-na.omit(ddply(res$split.data,.(edugp,Birth_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
 
P_cohort<-ggplot(data = temp.data,aes(x = Birth_F, y = Rate*10^3,color=factor(edugp))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Birth Cohort") + ylab("MCI Rate Per 1000") + 
  ggtitle("Birth Cohort-Specific MCI Incidence Rate by Education Level") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,250,by=50),lty="dashed",colour="black") + 
  theme(legend.justification=c(0.9,1),  
        legend.position=c(0.9,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=12,face="bold"), 
        legend.text=element_text(colour="black",size=12,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
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        plot.title=element_text(colour="black",  size=16,face="bold"), 
        axis.text.x = element_text(angle=45,hjust=1) 
         
  ) + 
   
  scale_colour_discrete(name = "",labels=c("<High School","High School",">High School")) + 
  scale_x_continuous(breaks=c(1895,1900,1905,1910,1915,1920,1925,1930,1935,1940), 
labels=c("1895-99","1900-04","1905-09","1910-14","1915-19","1920-24","1925-29", 
                              "1930-34","1935-39","1940 +")) + 
  scale_y_continuous(breaks=seq(0,250,by=50)) 
 
png("Figure1_5_Cohort-Specific MCI Incidence Rate by education.png",width=800,height=800,res=100) 
P_cohort 
dev.off() 
 
#----Thesis Data   Part (IV) Interaction with Allele----#                                                                                
#-----Figure 12. Age-specific MCI incidence rate by APOE4------# 
 
Lex.data<-Lex.data[which(Lex.data$age>=65),] 
res<-
acpSplit(indata=Lex.data,age.breaks=seq(65,105,by=5),per.breaks=seq(1985,2020,by=5),birth.breaks=seq(1895,1945,by
=5)) 
 
temp.data<-na.omit(ddply(res$split.data,.(allele,Age_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
temp.data<-temp.data[temp.data$Age_F<100,] 
P_age<-ggplot(data = temp.data,aes(x = Age_F, y = Rate*10^3,color=factor(allele))) + 
   geom_line(lwd=1.5) + 
   geom_point(size=3) + 
   xlab("Age") + ylab("MCI Rate Per 1000") + 
   ggtitle("Age-Specific MCI Incidence Rate by Allele") + 
   theme_bw() + 
   geom_hline(yintercept=seq(0,120,by=20),lty="dashed",colour="black") + 
  theme(legend.justification=c(0,1),  
          legend.position=c(0,1), 
          legend.background=element_blank(), 
          panel.grid.major = element_blank(), 
          panel.grid.minor = element_blank(), 
          axis.line = element_line(colour = "black",size=1), 
          legend.title=element_text(colour="blue",size=10,face="bold"), 
          legend.text=element_text(colour="black",size=10,face="bold"), 
          legend.key=element_blank(), 
          axis.title = element_text(colour="black",size=15,face="bold"), 
axis.text = element_text(colour="black", size=12,face="bold"), 
plot.title=element_text(colour="black",  size=16,face="bold")) +   
   scale_colour_discrete(name = "",labels=c("non-APOE4","APOE*4")) + 
   scale_x_continuous(breaks=c(65,70,75,80,85,90,95), 
labels=c("65-69", "70-74","75-79","80-84","85-89","90-94","95-99")) + 
   scale_y_continuous(breaks=seq(0,120,by=20)) 
 
png("Figure1_5_Age-Specific MCI Incidence Rate by allele.png",width=800,height=800,res=100) 
P_age 
dev.off() 
 
#-----Figure 13. Period-specific MCI incidence rate by APOE4------# 
 
temp.data<-na.omit(ddply(res$split.data,.(allele,Per_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
 
P_period<-ggplot(data = temp.data,aes(x = Per_F, y = Rate*10^3,color=factor(allele))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Period") + ylab("MCI Rate Per 1000") + 
  ggtitle("Period-Specific MCI Incidence Rate by Allele") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,80,by=20),lty="dashed",colour="black") + 
  theme(legend.justification=c(0,0.9),  
        legend.position=c(0,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
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        legend.title=element_text(colour="blue",size=10,face="bold"), 
        legend.text=element_text(colour="black",size=10,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold")) + 
   
  scale_colour_discrete(name = "",labels=c("non-APOE4","APOE*4")) + 
  scale_x_continuous(breaks=c(1985,1990,1995,2000,2005,2010,2015), 
                     labels=c("1985-89","1990-94","1995-99","2000-04","2005-09","2010-14","2015 +")) + 
  scale_y_continuous(breaks=seq(0,80,by=20)) 
 
png("Figure1_5_Period-Specific MCI Incidence Rate by allele.png",width=800,height=800,res=100) 
P_period 
dev.off() 
 
#-----Figure 14. Cohort-specific MCI incidence rate by APOE4------# 
 
temp.data<-na.omit(ddply(res$split.data,.(allele,Birth_F),summarize,Rate=sum(lex.Xst)/sum(lex.dur))) 
 
P_cohort<-ggplot(data = temp.data,aes(x = Birth_F, y = Rate*10^3,color=factor(allele))) + 
  geom_line(lwd=1.5) + 
  geom_point(size=3) + 
  xlab("Birth Cohort") + ylab("MCI Rate Per 1000") + 
  ggtitle("Birth Cohort-Specific MCI Incidence Rate by Allele") + 
  theme_bw() + 
  geom_hline(yintercept=seq(0,160,by=20),lty="dashed",colour="black") + 
  theme(legend.justification=c(0.9,1),  
        legend.position=c(0.9,1), 
        legend.background=element_blank(), 
        panel.grid.major = element_blank(), 
        panel.grid.minor = element_blank(), 
        axis.line = element_line(colour = "black",size=1), 
        legend.title=element_text(colour="blue",size=12,face="bold"), 
        legend.text=element_text(colour="black",size=12,face="bold"), 
        legend.key=element_blank(), 
        axis.title = element_text(colour="black",size=15,face="bold"), 
        axis.text = element_text(colour="black", size=12,face="bold"), 
        plot.title=element_text(colour="black",  size=16,face="bold")) + 
   
  scale_colour_discrete(name = "",labels=c("non-APOE4","APOE*4")) + 
  scale_x_continuous(breaks=c(1895,1900,1905,1910,1915,1920,1925,1930,1935,1940), 
labels=c("1895-99","1900-04","1905-09","1910-14","1915-19","1920-24","1925-29", 
                              "1930-34","1935-39","1940 +")) + 
  scale_y_continuous(breaks=seq(0,160,by=20)) 
 
 
png("Figure1_5_Cohort-Specific MCI Incidence Rate by allele.png",width=800,height=800,res=100) 
P_cohort 
dev.off() 
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APPENDIX B: SUPPLEMENTARY TABLES 
Table 21. Supplementary Table 1. Data Information  
Variable name in the dataset interpretation Unit or level 
Research ID ID of participants Integer, 1, 2… 
Age1 Age at baseline year 
Study 
Data collected from which 
study 
1 = MoVIES 
2 = MYHAT 
Mcesdscore Depression scale 0-?? 
Smokeyr (at     
baseline) 
The smoking history at 
baseline 
1 = yes 
0 = no 
Birthyr Year of birth Calendar year 
DTBIR Date of birth date 
APOE*4 allele  
1 = ApoE4 Positive 
0 = ApoE4 Negative 
Sexf gender 
1 = female 
0 = male 
Edugp Education Level 
0 means less than HS 
1 = HS 
2 > HS 
Case Reach CDR=0.5 
1 = case 
0 = non-case 
Intdt1 First interview date Calendar date 
LTFUDT last follow-up date Calendar date 
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Table 22. Supplementary Table 2. Information of MoVIES and MYHAT Study Population  
 MoVIES MYHAT 
Age at study entry in years >=65 >=65 
Time of entering the study 
in calendar year 1987-1989 2006-2008 
Follow-up period in years Over 15 years Over 10 years 
Follow-up frequency Every 2 years Annually 
Recruited participants 1,608 1,413 
 
Table 23. Supplementary Table 3. Poisson log-linear model with age effects by gender  
 
Estimate Std. Error z value Pr(>|z|) *P-value* 
(Intercept) -5.166 0.707 -7.308 0.000 
 A70-74 0.582 0.756 0.770 0.442 
 A75-79 1.322 0.724 1.828 0.068 
 A80-84 2.061 0.717 2.873 0.004 
 A85-89 2.527 0.719 3.517 0.000 
 A90-94 2.773 0.731 3.794 0.000 
 A95-99 3.065 0.782 3.921 0.000 
 sexf 1.043 0.790 1.320 0.187 
 A70:sexf -1.155 0.864 -1.338 0.181 
 A75:sexf -1.153 0.815 -1.415 0.157 
 A80:sexf -1.020 0.805 -1.267 0.205 
 A85:sexf -0.984 0.806 -1.221 0.222 
 A90:sexf -0.829 0.820 -1.011 0.312 
 A95:sexf -0.862 0.893 -0.965 0.335 0.75 
*P-value by LRT for overall all the interaction terms 
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Table 24. Supplementary Table 3.1 Poisson log-linear model with age and gender effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -4.467 0.320 -13.957 0.000 
A70-74 -0.218 0.360 -0.605 0.545 
A75-79 0.522 0.331 1.578 0.115 
A80-84 1.343 0.324 4.140 0.000 
A85-89 1.833 0.325 5.639 0.000 
A90-94 2.188 0.331 6.607 0.000 
A95-99 2.446 0.374 6.538 0.000 
sexf 0.052 0.083 0.627 0.531 
 
Table 25. Supplementary Table 4. Poisson log-linear model with period effects by gender 
 
Estimate Std. Error z value Pr(>|z|) *P-value 
(Intercept) -4.200 0.267 -15.717 0.000 
 P1990-1994 0.721 0.294 2.450 0.014 
 P1995-1999 0.685 0.316 2.166 0.030 
 P2005-2009 1.530 0.293 5.213 0.000 
 P2010-2014 0.829 0.313 2.653 0.008 
 P2015+ 0.657 0.756 0.869 0.385 
 sexf -0.053 0.356 -0.149 0.882 
 P1990:sexf -0.204 0.392 -0.519 0.603 
 P1995:sexf 0.234 0.410 0.572 0.567 
 P2005:sexf 0.214 0.386 0.556 0.578 
 P2010:sexf 0.320 0.405 0.789 0.430 
 P2015:sexf 0.696 0.859 0.810 0.418 0.270 
  *P-value by LRT for overall all the interaction terms 
 
Table 26. Supplementary Table 4.1. Poisson log-linear model with period and gender effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -4.275 0.183 -23.300 0.000 
P1990-1994 0.594 0.195 3.053 0.002 
P1995-1999 0.832 0.200 4.170 0.000 
P2005-2009 1.661 0.190 8.748 0.000 
P2010-2014 1.035 0.198 5.237 0.000 
P2015+ 1.169 0.350 3.342 0.001 
sexf 0.076 0.083 0.916 0.360 
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Table 27. Supplementary Table 5. Poisson log-linear model with cohort effects by gender* 
 
Estimate Std. Error z value Pr(>|z|) p-value 
(Intercept) -16.039 773.784 -0.021 0.983 
 C1900-1904 13.854 773.784 0.018 0.986 
 C1905-1909 13.317 773.784 0.017 0.986 
 C1910-1914 12.884 773.784 0.017 0.987 
 C1915-1919 12.370 773.784 0.016 0.987 
 C1920-1924 12.466 773.784 0.016 0.987 
 C1925-1929 13.308 773.784 0.017 0.986 
 C1930-1934 12.767 773.784 0.016 0.987 
 C1935-1939 12.034 773.784 0.016 0.988 
 C1940+ 11.411 773.784 0.015 0.988 
 sexf 15.517 773.784 0.020 0.984 
 C1900:sexf -16.330 773.784 -0.021 0.983 
 C1905:sexf -15.499 773.784 -0.020 0.984 
 C1910:sexf -15.641 773.784 -0.020 0.984 
 C1915:sexf -15.406 773.784 -0.020 0.984 
 C1920:sexf -15.431 773.784 -0.020 0.984 
 C1925:sexf -15.156 773.784 -0.020 0.984 
 C1930:sexf -15.536 773.784 -0.020 0.984 
 C1935:sexf -15.407 773.784 -0.020 0.984 
 C1940:sexf -14.758 773.784 -0.019 0.985 0.31 
*Model fitting does not converge 
 
Table 28. Supplementary Table 5.1. Poisson log-linear model with cohort and gender effects 
 
Estimate Std. Error z value Pr(>|z|) 
(Intercept) -1.547 0.708 -2.185 0.029 
C1900-1904 -1.275 0.754 -1.692 0.091 
C1905-1909 -1.228 0.719 -1.709 0.088 
C1910-1914 -1.752 0.715 -2.450 0.014 
C1915-1919 -2.113 0.713 -2.964 0.003 
C1920-1924 -2.033 0.713 -2.852 0.004 
C1925-1929 -1.008 0.714 -1.412 0.158 
C1930-1934 -1.805 0.723 -2.497 0.013 
C1935-1939 -2.449 0.731 -3.348 0.001 
C1940+ -2.602 0.756 -3.441 0.001 
sexf 0.096 0.085 1.137 0.255 
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Table 29. Supplementary Table 6. Poisson log-linear model with age effects by education 
 
Estimate Std. Error z value Pr(>|z|) *p-value 
(Intercept) -3.996 0.577 -6.921 0.000 
 A70-74 -0.375 0.658 -0.570 0.569 
 A75-79 -0.055 0.611 -0.091 0.928 
 A80-84 1.215 0.588 2.068 0.039 
 A85-89 1.404 0.592 2.373 0.018 
 A90-94 1.882 0.600 3.138 0.002 
 A95-99 1.570 0.707 2.220 0.026 
 Edugp1 -0.467 0.764 -0.611 0.541 
 Edugp2 -0.733 0.816 -0.898 0.369 
 A70:edugp1 0.180 0.869 0.207 0.836 
 A75:edugp1 0.601 0.804 0.748 0.454 
 A80:edugp1 0.179 0.780 0.230 0.818 
 A85:edugp1 0.567 0.785 0.723 0.470 
 A90:edugp1 0.335 0.799 0.420 0.675 
 A95:edugp1 1.069 0.917 1.166 0.244 
 A70:edugp2 0.233 0.931 0.251 0.802 
 A75:edugp2 0.980 0.856 1.145 0.252 
 A80:edugp2 -0.086 0.840 -0.102 0.919 
 A85:edugp2 0.604 0.838 0.721 0.471 
 A90:edugp2 0.467 0.852 0.548 0.584 
 A95:edugp2 1.396 0.979 1.426 0.154 0.130 
  *P-value by LRT for overall all the interaction terms 
  Edugp1: Participants receiving HS education; Edugp2: Participants receiving higher than HS education 
 
 
Table 30. Supplementary Table 7. Poisson log-linear model with period effects by education 
 
Estimate Std. Error z value Pr(>|z|) *p-value 
(Intercept) -3.823 0.218 -17.519 0.000 
 P1990-1904 0.565 0.244 2.319 0.020 
 P1995-1999 0.727 0.259 2.813 0.005 
 P2005-2009 1.825 0.273 6.681 0.000 
 P2010-2014 1.442 0.302 4.778 0.000 
 P2015+ 1.683 1.024 1.644 0.100 
 edugp1 -1.388 0.546 -2.544 0.011 
 edugp2 -0.469 0.436 -1.075 0.282 
 P1990:edugp1 0.664 0.579 1.146 0.252 
 P1995:edugp1 0.847 0.588 1.441 0.150 
 P2005:edugp1 0.881 0.579 1.522 0.128 
 P2010:edugp1 0.620 0.600 1.034 0.301 
 P2015:edugp1 0.168 1.277 0.131 0.896 
 P1990:edugp2 -0.361 0.492 -0.734 0.463 
 P1995:edugp2 0.018 0.495 0.036 0.971 
 P2005:edugp2 -0.444 0.482 -0.920 0.357 
 P2010:edugp2 -0.751 0.508 -1.479 0.139 
 P2015:edugp2 -0.527 1.179 -0.447 0.655 0.360 
  *P-value by LRT for overall all the interaction terms 
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Table 31. Supplementary Table 8. Poisson log-linear model with cohort effects by education 
 
Estimate Std. Error z value Pr(>|z|) *p-value 
(Intercept) -1.395 1.000 -1.395 0.163 
 C1900-1904 -1.586 1.069 -1.484 0.138 
 C1905-1909 -1.240 1.012 -1.225 0.221 
 C1910-1914 -1.580 1.008 -1.567 0.117 
 C1915-1919 -2.031 1.010 -2.011 0.044 
 C1920-1924 -2.193 1.018 -2.155 0.031 
 C1925-1929 -0.606 1.031 -0.588 0.557 
 C1930-1934 -1.270 1.069 -1.188 0.235 
 C1935-1939 -2.540 1.225 -2.074 0.038 
 C1940+ -0.419 1.118 -0.375 0.708 
 edugp1 -2.148 0.671 -3.202 0.001 
 edugp2 -0.217 1.414 -0.154 0.878 
 C1900:edugp1 2.713 0.918 2.955 0.003 
 C1905:edugp1 1.794 0.800 2.241 0.025 
 C1910:edugp1 1.920 0.717 2.678 0.007 
 C1915:edugp1 1.807 0.701 2.577 0.010 
 C1920:edugp1 2.235 0.709 3.153 0.002 
 C1925:edugp1 1.654 0.728 2.272 0.023 
 C1930:edugp1 1.766 0.797 2.217 0.027 
 C1935:edugp1 2.208 1.013 2.179 0.029 
 C1900:edugp2 0.655 1.547 0.424 0.672 
 C1905:edugp2 0.066 1.446 0.046 0.964 
 C1910:edugp2 -0.944 1.455 -0.649 0.516 
 C1915:edugp2 0.041 1.434 0.029 0.977 
 C1920:edugp2 0.297 1.435 0.207 0.836 
 C1925:edugp2 -0.426 1.445 -0.295 0.768 
 C1930:edugp2 -0.844 1.486 -0.568 0.570 
 C1935:edugp2 0.174 1.604 0.109 0.913 
 C1940:edugp2 -2.662 1.565 -1.701 0.089 0.048 
  *P-value by LRT for overall all the interaction terms 
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Table 32. Supplementary Table 9. Poisson log-linear model with age effects by ApoE4 
 
Estimate Std. Error z value Pr(>|z|) *P-value 
(Intercept) -4.058 0.333 -12.173 0.000 
 A70-74 -0.957 0.422 -2.269 0.023 
 A75-79 0.012 0.357 0.034 0.973 
 A80-84 0.905 0.346 2.618 0.009 
 A85-89 1.387 0.346 4.002 0.000 
 A90-94 1.774 0.354 5.014 0.000 
 A95-99 2.037 0.405 5.034 0.000 
 Allele -0.986 1.054 -0.936 0.350 
 A70:Allele 1.748 1.135 1.540 0.124 
 A75:Allele 1.396 1.081 1.292 0.196 
 A80:Allele 1.169 1.071 1.091 0.275 
 A85:Allele 1.187 1.073 1.107 0.268 
 A90:Allele 1.277 1.085 1.177 0.239 
 A95:Allele 1.004 1.290 0.779 0.436 0.660 
  *P-value by LRT for overall all the interaction terms 
 
Table 33. Supplementary Table 10. Poisson log-linear model with period effects by ApoE4  
 
Estimate Std. Error z value Pr(>|z|) *p-value 
(Intercept) -4.832 0.354 -13.668 0.000 
 P1990-1994 0.968 0.373 2.594 0.009 
 P1995-1999 1.412 0.370 3.815 0.000 
 P2005-2009 2.222 0.363 6.120 0.000 
 P2010-2014 1.522 0.370 4.119 0.000 
 P2015+ 1.881 0.486 3.871 0.000 
 Allele -0.128 0.790 -0.161 0.872 
 P1990:Allele 0.257 0.829 0.311 0.756 
 P1995:Allele 0.151 0.825 0.183 0.855 
 P2005:Allele 0.208 0.810 0.257 0.797 
 P2010:Allele 0.669 0.815 0.821 0.412 
 P2015:Allele 0.037 1.112 0.034 0.973 0.510 
  *P-value by LRT for overall all the interaction terms 
 
 
57 
Table 34. Supplementary Table 11. Poisson log-linear model with cohort effects by ApoE4 
 
Estimate Std. Error z value Pr(>|z|) *P-value 
(Intercept) -2.432 1.000 -2.432 0.015 
 C1900-1904 -0.465 1.118 -0.416 0.677 
 C1905-1909 -0.303 1.017 -0.298 0.766 
 C1910-1914 -0.649 1.008 -0.644 0.520 
 C1915-1919 -1.113 1.006 -1.106 0.269 
 C1920-1924 -1.110 1.006 -1.104 0.270 
 C1925-1929 -0.164 1.007 -0.163 0.871 
 C1930-1934 -0.789 1.015 -0.777 0.437 
 C1935-1939 -1.833 1.033 -1.775 0.076 
 C1940+ -1.732 1.049 -1.651 0.099 
 Allele 0.211 0.658 0.320 0.749 
 C1900:Allele 0.342 1.008 0.339 0.735 
 C1905:Allele -0.084 0.769 -0.109 0.913 
 C1910:Allele -0.844 0.769 -1.097 0.273 
 C1915:Allele -0.096 0.695 -0.138 0.890 
 C1920:Allele -0.051 0.694 -0.074 0.941 
 C1925:Allele 0.302 0.692 0.436 0.663 
 C1930:Allele -0.223 0.750 -0.298 0.766 
 C1935:Allele 0.654 0.775 0.844 0.398 0.220 
  *P-value by LRT for overall all the interaction terms 
 
Table 35. Supplementary Table 12. Poisson log-linear model with age effects by study 
 
Estimate Std. Error z value Pr(>|z|) *P-value 
(Intercept) -6.280 1.000 -6.280 0.000 
 A70-74 1.347 1.027 1.311 0.190 
 A75-79 2.183 1.008 2.166 0.030 
 A80-84 3.016 1.004 3.002 0.003 
 A85-89 3.451 1.007 3.427 0.001 
 A90-94 3.834 1.017 3.772 0.000 
 A95-99 4.135 1.080 3.829 0.000 
 Study 2.737 1.054 2.597 0.009 
 A70:Study -2.003 1.109 -1.806 0.071 
 A75:Study -2.164 1.073 -2.017 0.044 
 A80:Study -2.268 1.064 -2.131 0.033 
 A85:Study -2.327 1.065 -2.185 0.029 
 A90:Study -2.441 1.076 -2.268 0.023 
 A95:Study -2.528 1.153 -2.192 0.028 0.130 
  *P-value by LRT for overall all the interaction terms 
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